Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Mesenchymal cells for skeletal tissue engineering EXPERT OPINION ON BIOLOGICAL THERAPY Slater, B. J., Kwan, M. D., Gupta, D. M., Panetta, N. J., Longaker, M. 2008; 8 (7): 885-893

Abstract

Skeletal defects represent a significant socioeconomic burden to the US healthcare system. Current options for reconstructing osseous deficits have shortcomings.To review the use of mesenchymal stem cells for skeletal tissue engineering.We focused on the application of mesenchymal cells in skeletal regeneration, optimization of this technique, tropic effects of multipotent mesenchymal cells, and future directions.A number of cell-based modalities have been investigated. We have been interested in the role of adipose-derived stromal cells in bone regeneration and understanding the mechanisms behind osteogenic differentiation of progenitor cells and acceleration of this process. Future clinical applications of multipotent mesenchymal cells will depend on better understanding of the molecular signaling involved in osteogenic differentiation and maintaining pluripotency.

View details for DOI 10.1517/14712590802120981

View details for Web of Science ID 000257408000004

View details for PubMedID 18549320